CliffBio

Amgen

Patent cliffs & loss of exclusivity

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company founded in 1980 with headquarters in Thousand Oaks, California.

Company

Also Known AsAmgen Inc.
AngelList URLhttps://angel.co/amgen
Apple App Store URLhttps://apps.apple.com/us/developer/amgen-inc/id434433950
Bloghttps://www.amgenbiotechexperience.com/blog
CAGE Code0JVZ6
Legal NameAmgen Limited
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/amgen-2

24 upcoming patent cliffs

DrugIngredientTypeCliff
  1. Epogen/Procritepoetin alfaBiologicJun 2001
  2. Epogen/Procritepoetin alfaBiologicJun 2001
  3. Epogen/Procritepoetin alfaBiologicJun 2001
  4. Epogen/Procritepoetin alfaBiologicJun 2001
  5. NeupogenfilgrastimBiologicFeb 2003
  6. NeupogenfilgrastimBiologicFeb 2003
  7. NeupogenfilgrastimBiologicJun 2012
  8. NeupogenfilgrastimBiologicJun 2012
  9. Aranespdarbepoetin alphaBiologicSep 2013
  10. Aranespdarbepoetin alphaBiologicSep 2013
  11. Aranespdarbepoetin alphaBiologicSep 2013
  12. Aranespdarbepoetin alphaBiologicSep 2013
  13. Aranespdarbepoetin alphaBiologicSep 2013
  14. NeulastapegfilgrastimBiologicJan 2014
  15. Aranespdarbepoetin alphaBiologicDec 2015
  16. Aranespdarbepoetin alphaBiologicDec 2015
  17. Aranespdarbepoetin alphaBiologicDec 2015
  18. Aranespdarbepoetin alphaBiologicDec 2015
  19. Aranespdarbepoetin alphaBiologicDec 2015
  20. Aranespdarbepoetin alphaBiologicDec 2015
  21. Aranespdarbepoetin alphaBiologicDec 2015
  22. Aranespdarbepoetin alphaBiologicDec 2015
  23. VectibixpanitumumabBiologicSep 2018
  24. VectibixpanitumumabBiologicSep 2018
  25. NplateromiplostimBiologicAug 2020
  26. NplateromiplostimBiologicAug 2020
  27. ProliadenosumabBiologicJun 2022
  28. XgevadenosumabBiologicNov 2022
  29. SENSIPARCINACALCET HYDROCHLORIDESmall mol.Sep 2026
  30. SENSIPARCINACALCET HYDROCHLORIDESmall mol.Sep 2026
  31. SENSIPARCINACALCET HYDROCHLORIDESmall mol.Sep 2026
  32. BlincytoblinatumomabBiologicDec 2026
  33. CORLANORIVABRADINESmall mol.Dec 2026
  34. Neulasta OnpropegfilgrastimBiologicDec 2026
  35. CORLANORIVABRADINE HYDROCHLORIDESmall mol.Jun 2027
  36. CORLANORIVABRADINE HYDROCHLORIDESmall mol.Jun 2027
  37. RepathaevolocumabBiologicAug 2027
  38. ImlygicTalimogene laherparepvecBiologicOct 2027
  39. ImlygicTalimogene laherparepvecBiologicOct 2027
  40. Aimovigerenumab-aooeBiologicMay 2030
  41. Aimovigerenumab-aooeBiologicMar 2031
  42. Evenityromosozumab-aqqgBiologicApr 2031
  43. NplateromiplostimBiologicJul 2031
  44. OTEZLAAPREMILASTSmall mol.Nov 2034
  45. OTEZLAAPREMILASTSmall mol.Nov 2034
  46. OTEZLAAPREMILASTSmall mol.Nov 2034
  47. Imdelltratarlatamab-dlleBiologicMay 2036
  48. Imdelltratarlatamab-dlleBiologicMay 2036
  49. LUMAKRASSOTORASIBSmall mol.Sep 2040
  50. LUMAKRASSOTORASIBSmall mol.Sep 2040
  51. LUMAKRASSOTORASIBSmall mol.Sep 2040
  52. OTEZLA XRAPREMILASTSmall mol.May 2042
  53. Epogen/Procritepoetin alfaBiologic—
  54. Epogen/Procritepoetin alfaBiologic—
  55. Procritepoetin alfaBiologic—
  56. Aranespdarbepoetin alphaBiologic—
  57. Amjevitaadalimumab-attoBiologic—
  58. Amjevitaadalimumab-attoBiologic—
  59. Amjevitaadalimumab-attoBiologic—
  60. Amjevitaadalimumab-attoBiologic—
  61. Amjevitaadalimumab-attoBiologic—
  62. Amjevitaadalimumab-attoBiologic—
  63. Amjevitaadalimumab-attoBiologic—
  64. Amjevitaadalimumab-attoBiologic—
  65. Amjevitaadalimumab-attoBiologic—
  66. Mvasibevacizumab-awwbBiologic—
  67. Mvasibevacizumab-awwbBiologic—
  68. Kanjintitrastuzumab-annsBiologic—
  69. Kanjintitrastuzumab-annsBiologic—
  70. Avsolainfliximab-axxqBiologic—
  71. Riabnirituximab-arrxBiologic—
  72. Riabnirituximab-arrxBiologic—
  73. Wezlanaustekinumab-auubBiologic—
  74. Wezlanaustekinumab-auubBiologic—
  75. Wezlanaustekinumab-auubBiologic—
  76. Wezlanaustekinumab-auubBiologic—
  77. Wezlanaustekinumab-auubBiologic—
  78. Pavbluaflibercept-ayyhBiologic—
  79. Pavbluaflibercept-ayyhBiologic—
  80. Wezlanaustekinumab-auubBiologic—
  81. Bkemveculizumab-aeebBiologic—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Amgen — patent cliffs & loss of exclusivity | CliffBio